After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...
Clinical trials are more connected and more closely examined than ever. Inspection readiness isn’t a last-minute document ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback